Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca recovery of global rights to brazikumab (MEDI2070) from Allergan completed
-
Lynparza approved in the US as 1st-line maintenance treatment with bevacizumab for HRD-positive advanced ovarian cancer
-
Farxiga approved in the US for the treatment of heart failure in patients with heart failure with reduced ejection fraction
-
AstraZeneca and Oxford University announce landmark agreement for COVID-19 vaccine
-
First-quarter 2020 results
-
Lynparza demonstrated overall survival benefit in Phase III PROfound trial for BRCA1/2 or ATM-mutated metastatic castration-resistant prostate cancer
-
AstraZeneca and Saint Luke’s Mid America Heart Institute initiate Phase III DARE-19 trial with Farxiga in COVID-19 patients
-
AstraZeneca initiates CALAVI clinical trial with Calquence against COVID-19
-
Koselugo (selumetinib) approved in US for paediatric patients with neurofibromatosis type 1 plexiform neurofibromas
-
Tagrisso Phase III ADAURA trial will be unblinded early after overwhelming efficacy in the adjuvant treatment of patients with EGFR-mutated lung cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
